Researcher.Life Logo

Acta Biomaterialia : Impact Factor & More

eISSN: 1878-7568pISSN: 1742-7061

Aims and Scope of Acta Biomaterialia

Acta Biomaterialia is a monthly peer-reviewed scientific journal published by Elsevier. It is published on behalf of Acta Materialia, Inc., and is sponsored by ASM International and The Minerals, Metals & Materials Society. The journal was established in January 2005. The editor-in-chief is W.R. Wagner (University of Pittsburgh). The journal covers research in biomaterials science, including the interrelationship of biomaterial structure and function from macroscale to nanoscale. Topical coverage includes biomedical and biocompatible materials. Less

Key Metrics

CiteScore
15.6
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
Scite Index
0.94 5-Year SI
SJR
Q1Biochemistry
SNIP
1.83
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Acta Biomaterialia

Acta Biomaterialia Journal Specifications

Overview
Publisher ELSEVIER SCI LTD
Language English
Frequency Semi-monthly
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year2005
Publisher URLVisit website
View less

Planning to publish in Acta Biomaterialia ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Acta Biomaterialia

An efficient framework to assess the predictive value of 4D ultrasound-based wall motion indices for abdominal aortic aneurysm rupture risk stratification.
  • 1 Jun 2026
  • Acta biomaterialia
A quantitative approach for high-throughput mapping of collagen fibril orientation using polarization-dependent Second Harmonic Generation.
  • 1 Jun 2026
  • Acta biomaterialia
Adhesive polyethylene glycol hydrogels with metformin enabling in-situ drug delivery reprogramming immuno-metabolism for tissue repair in diabetic foot ulcers.
  • 1 Jun 2026
  • Acta biomaterialia
Citrate-functionalised hydroxyapatite mimics the microenvironment of bone metastases and demonstrates the role of citrate in prostate cancer colonization of bone.
  • 1 Jun 2026
  • Acta biomaterialia
Stimuli-responsive copper-iodide nanoparticles for low-dose X-ray-induced photodynamic therapy and enhanced cuproptosis.
  • 1 Jun 2026
  • Acta biomaterialia
Biomaterials for endometriosis treatment: Design, advances, and prospects.
  • 1 Jun 2026
  • Acta biomaterialia
An efficient framework to assess the predictive value of 4D ultrasound-based wall motion indices for abdominal aortic aneurysm rupture risk stratification.
  • 1 Jun 2026
  • Acta biomaterialia
A quantitative approach for high-throughput mapping of collagen fibril orientation using polarization-dependent Second Harmonic Generation.
  • 1 Jun 2026
  • Acta biomaterialia
Adhesive polyethylene glycol hydrogels with metformin enabling in-situ drug delivery reprogramming immuno-metabolism for tissue repair in diabetic foot ulcers.
  • 1 Jun 2026
  • Acta biomaterialia
Citrate-functionalised hydroxyapatite mimics the microenvironment of bone metastases and demonstrates the role of citrate in prostate cancer colonization of bone.
  • 1 Jun 2026
  • Acta biomaterialia
Stimuli-responsive copper-iodide nanoparticles for low-dose X-ray-induced photodynamic therapy and enhanced cuproptosis.
  • 1 Jun 2026
  • Acta biomaterialia
Biomaterials for endometriosis treatment: Design, advances, and prospects.
  • 1 Jun 2026
  • Acta biomaterialia

FAQs on Acta Biomaterialia